SEPTAL CRT is a prospective, randomised trial designed to investigate the long-term clinical efficacy and patient outcomes of placing a right ventricular defibrillator lead in different areas of the heart for patients implanted with a Boston Scientific cardiac resynchronisation defibrillator (CRT-D). Patients will be implanted with a RELIANCE

«« Philips Sets New Standard to Improve Detection and Identification of Heart Disease


2.4 Million Euros for Promotion of Healing Process After A Heart Attack »»


Latest Articles

SEPTAL CRT is a prospective, randomised trial designed to investigate the long-term clinical efficacy and patient outcomes of placing a right ventricular...